Dr. Barry Dworkin

House Calls, #951, December 15, 2024: Eli Lilly Levies Fat Tax on Weight Loss Drug

Dr. Yoni Freedhoff joins me today to discuss the decision by Eli Lilly, manufacturer of Mounjaro, to charge more for patients who are suffering with the affects of obesity. In fact the cost will be double that of people using it for the treatment of their type 2 diabetes.

Your Calls and Comments:

  • The effects of the common cold for someone who has type 2 diabetes
  • A man is spitting up frequently at night but not during the day. Likely experiencing relux.

Related posts:

  1. Sunday House Call, #386, February 26, 2012
  2. Sunday House Call, #753, August 23, 2020: Stop the old canards about #obesity and start treating it like the chronic disease it is by providing therapeutic support as outlined in the new Canadian management guidelines.
  3. Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.
  4. A step forward for management of obesity with approval of semaglutide by FDA. @YoniFreedhoff joins me to discuss fat shaming, weight bias and how we need to turn this around and help those suffering with obesity as we would with any other chronic disease.